Dr. Barry Dworkin

Time Magazine piece on treatment of early Alzheimer’s Disease lacks balance. It reads as an ad for pharma company that made it. Side effects glossed over and relative instead of absolute risk reported. Clinical outcomes overstated.

Medical Mythbusting Commentary for October 27, 2023

Source:
Why Diagnosing Alzheimer’s Early Is So Important

Reference:
Lecanemab for Alzheimer’s disease: tempering hype and hope

Related posts:

  1. Common medications are associated with diminish brain function and size.
  2. Meds put seniors at higher risk of falls
  3. Study indicates drug used for early Alzheimer Disease is helpful in later stages
  4. Lack of evidence has not stopped increased use of antipsychotic meds to calm agitated elderly